[1] Johnson ME, Murphy PJ. Changes in the tear film and oc-ular surface from dry eye syndrome [J]. Prog Retin Eye Res,2004,23(4):449-474. [2] International Dry Eye WorkShop Study Group. The defini-tion and classification of dry eye disease: report of the Def-inition and Classification Subcommittee of the Inter- na-tional Dry Eye WorkShop [J]. Ocul Surf, 2007,5(2):75-92. [3] 赵朋生.不同药物治疗白内障术后干眼症的疗效比较观察[J].中 国城乡企业卫生,2020,35(7):167-168. [4] 刘祖国,谢立信,孙旭光,等.干眼临床诊疗专家共识(2013年)[J]. 中华眼科杂志,2013,49(1):73-75. [5] 胡军华,刘春兰,夏侯梨,等.不同人工泪液治疗白内障超声乳化 术后干眼症临床效果观察[J].医学理论与实践,2019,32(3): 391-392. [6] Comstock TL, Decory HH. Advances in corticosteroid therapy for ocular inflammation: loteprednol etabonate [J]. Int J Inflam, 2012,2012:789623. [7] Pinto- Fraga J, Lopez- Miguel A, Gonzalez- Garcia MJ, et al. Topical fluorometholoneprotects the ocular surface of dry eye patients from desiccating stress: arandomized con-trolled clinical trial [J]. Ophthalmology, 2016,123(1):141-153. [8] 陈水花.氟米龙联合玻璃酸钠治疗白内障术后中重度干眼症的疗 效观察[J].临床合理用药杂志,2019,12(14):84-85.